Prof. dr. Esther WOLFS
View the content of this page
View the content of this page
Prof. dr. Esther WOLFS
Associate Professor
Prof. dr. Esther WOLFS
Research
Discipline codes: Nuclear imaging (03061804), Medical imaging and therapy not elsewhere classified (03061899), Cell therapy (03063201), Neurological and neuromuscular diseases (03062305), Cancer therapy (03062405)
Supervised PhDs
Turning the tide in stroke recovery: IGF-2 as a driver of neuroprotection, angiogenesis and neurogenesis.
Lotte Alders for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Copromotor
Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity
Kim Nijsten for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
Spatial statistical methods in digital pathology applied to non-small cell lung cancer and chronic hepatitis B infected liver tissue
Jari Claes for the title Doctor of Sciences: Statistics (doctorate in progress)
Supervised as Copromotor
The molecular hug between the ER and mitochondria in Charcot-Marie-Tooth disease type 1A
Hanne Jeurissen for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
An innovative nanocarrier-based drug delivery system to treat head and neck squamous cell carcinoma
Nuran Caz for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
Charcot-Marie-Tooth disease type 1A: a traffic jam at the Kennedy tunnel
Koen Kuipers for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Copromotor
Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A
Nathalie Dirkx for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing
Yara Lambrechts for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
Advancing precision oncology: Plasma-treated hydrogels as a targeted therapy for head and neck cancer
Thomas Raps for the title Doctor of Biomedical Sciences (doctorate in progress)
Supervised as Promotor
From Whole Slide Imaging Optimization to Nuclei Segmentation: Computational Approaches for Non-Small Cell Lung Cancer Analysis
Melvin Geubbelmans for the title Doctor of Sciences: Statistics in 2025
Supervised as Copromotor
From Experimental Models to Targeted Therapies for Oral Squamous Cell Carcinoma.
Jolien Van den Bosch for the title Doctor of Biomedical Sciences in 2025
Supervised as Promotor
Doxorubicin-induced cardiotoxicity: pyridoxamine to the rescue?
Sibren Haesen for the title Doctor of Biomedical Sciences in 2024
Supervised as Copromotor
Unraveling CMT1A: Models, Mechanisms, and Therapeutic Approaches
Karen Libberecht for the title Doctor of Biomedical Sciences in 2024
Supervised as Promotor
Human dental pulp stem cell-mediated mechanisms of neuroregeneration and optimization of the transient middle cerebral artery occlusion mouse stroke model
Pascal Gervois for the title Doctor of Biomedical Sciences in 2017
Supervised as Copromotor
Projects
36 research projects have been found
Engineering a nerve-in-a-dish: microtopography-guided differentiation of dental pulp stem cells for studying Charcot-Marie-Tooth disease. (Research)
01/10/2025 - 30/09/2029
Advancing precision oncology: Plasma-treated hydrogels as a targeted therapy for head and neck cancer (Research)
01/11/2024 - 31/10/2028
Beyond the biopsy: Innovative multimodal imaging to assess whole tumor heterogeneity in lung cancer (Research)
01/10/2025 - 30/09/2028
Plasma-treated hydrogels as a new selective therapy for head and neck cancer (Research)
01/01/2024 - 31/12/2027
Disturbances in Phospholipid Turnover in Charcot-Marie-Tooth disease Type 1A (Research)
01/11/2023 - 30/12/2027
Squeezing Cancer: Micro-Topographies to Decode Biological Pathways for Targeted HNSCC Therapeutics (Research)
01/10/2024 - 30/09/2027
Digital Pathology Innovations in Cross-Border Connectivity, AI and Mass Spectrometry (Research)
01/09/2024 - 31/08/2027
Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing. (Research)
01/01/2023 - 31/12/2026
Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)
01/11/2022 - 31/10/2026
Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)
01/11/2022 - 31/10/2026
Charcot-Marie-Tooth Disease Type 1A: Traffic jam at the Kennedy Tunnel. (Research)
01/11/2022 - 31/10/2026
StemServe: Validation of the business case for a proprietary collection of human stem cells (Research)
19/05/2025 - 18/05/2026
The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)
01/11/2023 - 31/10/2025
IGF-2 and Des(1-6)IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)
01/11/2023 - 31/10/2025
The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)
01/11/2021 - 31/10/2025
NEED - Bioresponsive nanocarriers as a therapy for cancer and wound healing. (Research)
01/01/2021 - 31/12/2024
Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity. (Research)
01/01/2021 - 31/12/2024
From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)
01/11/2022 - 31/10/2024
Creation of a humanized mouse model for Charcot Marie Tooth disease type 1A (Research)
01/10/2023 - 30/09/2024
Development of a new CMT1A research toolbox: an alternative human stem cell-based strategy (Research)
01/01/2022 - 31/05/2024
The next generation of transmission electron microscopy: from biomedicine to nanomaterials. A state-of-the art electron microscopy system for cryo-EM and correlative light and electron microscopy. (Research)
01/05/2020 - 30/04/2024
Dental stem cells as effective vehicles in a new therapy for oral squamous cell carcinoma. (Research)
01/01/2020 - 31/12/2023
The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)
01/11/2021 - 31/10/2023
IGF-2 and Des [1-6] IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)
01/11/2021 - 31/10/2023
Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)
01/11/2021 - 31/10/2023
IGF-2 and [DES-1-6]IGF-2 as new tools to boost neurogenesis after ischemic stroke (Research)
01/11/2020 - 31/10/2023
Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)
01/11/2019 - 31/10/2023
Charcot-Marie-Tooth disease, peripheral myelin protein 22, Schwann cells, dental pulp stem cells, induced pluripotent stem cells (Research)
01/10/2019 - 30/09/2023
Suicide gene therapy as a new treatment for oral squamous cell carcinoma: a dental stem cell-based approach. (Research)
01/10/2019 - 30/09/2023
From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)
01/11/2020 - 31/10/2022
Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)
01/11/2019 - 31/10/2021
Chemotherapy-induced cardiotoxicity: time for a chAnGE of stRAteGiEs. (Research)
01/11/2019 - 31/10/2020
ATMP Center: custom quality control & GMP services for clinical ATMP development (Research)
01/05/2019 - 30/04/2020
Education
Involved in the following courses
Academic year 2025 - 2026
Academic year 2025 - 2026
Academic year 2024 - 2025
Academic year 2024 - 2025
Esther WOLFS
Are you Esther WOLFS? Log in to edit this page